BREAKING NEWS

BREAKING NEWS

Johnson & Johnson's quarterly profit rises 3.3 pct

Now Reading:

Johnson & Johnson's quarterly profit rises 3.3 pct

Johnson & Johnson's quarterly profit rises 3.3 pct
Text size Aa Aa

(Reuters) - Johnson & Johnson <JNJ.N> reported a 3.3 percent rise in quarterly profit on Tuesday, as higher sales of cancer drugs Zytiga and Darzalex helped offset pressure on its blockbuster rheumatoid arthritis treatment Remicade.

The healthcare conglomerate's net earnings rose to $3.95 billion (3 billion pounds), or $1.45 per share, in the second quarter, from $3.83 billion, or $1.40 per share, a year earlier.

Sales rose to $20.83 billion from $18.84 billion.

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.